Psychemedics Q4 EPS $(0.86) Down From $(0.12) YoY, Sales $5.00M Down From $5.70M YoY
Portfolio Pulse from Benzinga Newsdesk
Psychemedics (NASDAQ:PMD) reported a significant decrease in its Q4 earnings per share (EPS) to $(0.86) from $(0.12) YoY, alongside a sales decrease to $5.00M from $5.70M YoY.
March 28, 2024 | 3:13 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Psychemedics reported a significant decrease in both EPS and sales in Q4, indicating a challenging period.
The substantial decrease in EPS and sales for Psychemedics suggests a challenging financial period for the company. Such negative financial performance is likely to impact investor sentiment and could lead to a decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100